Ország: Egyesült Királyság
Nyelv: angol
Forrás: MHRA (Medicines & Healthcare Products Regulatory Agency)
Calcium carbonate; Colecalciferol
Chiesi Ltd
A12AX
Calcium carbonate; Colecalciferol
1.5gram ; 400unit
Chewable tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 09060400; GTIN: 5028613002780
NATECAL D3 ISTRUZIONE VENDITA UK NERO 1 150 x 200/34 Tipo di materiale Descrizione Formato N. colori Colore 2 Colore 3 Colore 4 Colore 5 TACCHE LAETUS Corpo Colore 1 PELLICOLA DI PROPRIETÀ VIETATA LA MANOMISSIONE - RENDERE DOPO LA STAMPA 03-03-16 Cod. 01090/27 Destinazione Paese Codice PK81032 606 8 NUOVO TESTO PACKAGE LEAFLET: INFORMATION FOR THE USER Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor, pharmacist or nurse. • This medicine is for use in Adults only • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. In this leaflet: 1. What Natecal D3 is and what it is used for. 2. What you need to know before you take Natecal D3. 3. How to take Natecal D3. 4. Possible side effects. 5. How to store Natecal D3. 6. Contents of the pack and other information. 1. What Natecal D3 is and what it is used for Natecal D3 chewable tablets contain two active substances, calcium carbonate and cholecalciferol (vitamin D 3 ). Both calcium and vitamin D 3 are found in the diet and vitamin D is also produced in the skin after exposure to the sun. Natecal D3 chewable tablets may be prescribed by doctors to treat and prevent vitamin D/calcium deficiency. Natecal D 3 is used: - In the correction of calcium and vitamin D deficiencies in the elderly, - In combination with osteoporosis treatments where calcium and vitamin D levels are too low or where there is a high risk of them being too low. 2. What you need to know before you take Natecal D3 Do not take Natecal D3 • If you are hypersensitive to calcium, vitamin D 3 or to any of the other ingredients of Natecal D3 (in particular soya bean oil) Olvassa el a teljes dokumentumot
OBJECT 1 NATECAL D3 CHEWABLE TABLETS Summary of Product Characteristics Updated 07-Mar-2016 | Chiesi Limited 1. Name of the medicinal product NATECAL D3 600 mg + 400 I.U. chewable tablets 2. Qualitative and quantitative composition One tablet contains: Calcium carbonate 1500 mg (equivalent to 600 mg calcium) Cholecalciferol (Vitamin D 3 ) 400 I.U. (equivalent to 0.01 mg) Excipients: sorbitol, aspartame, lactose monohydrate, hydrogenated soya bean oil, sucrose For a full list of excipients, see section 6.1 3. Pharmaceutical form Chewable tablet The chewable tablet has a round, bevelled edge shape and is white to almost white with the inscription "D" on one side. 4. Clinical particulars 4.1 Therapeutic indications Correction of combined vitamin D and calcium deficiencies in the elderly; vitamin D and calcium supplementation as an adjunct to specific treatment for osteoporosis in patients where combined vitamin D and calcium deficiencies have been diagnosed or at a high risk of such deficiencies. 4.2 Posology and method of administration _ADULTS AND ELDERLY _ One tablet twice a day (e.g. one tablet in the morning and one tablet in the evening). Dose reduction should be considered as necessary following the monitoring of calcium levels as indicated in section 4.4 and 4.5. The tablets may be chewed or sucked, they should not be swallowed whole. The tablets should be taken preferably after meals. _DOSAGE IN PREGNANT WOMEN_ One tablet a day (see section 4.6). _DOSAGE IN HEPATIC IMPAIRMENT_ No dose adjustment is required. 4.3 Contraindications - Hypersensitivity to calcium, cholecalciferol or to any of the excipients (in particular soya bean oil) - Kidney stones (nephrolithiasis, nephrocalcinosis) - Severe renal impairment and renal failure - Hypercalciuria and hypercalcaemia and diseases and/or conditions resulting in hypercalcaemia and/or hypercalciuria (e.g. myeloma, bone metastases, primary hyperparathyroidism) - Hypervitaminosis D 4.4 Special warnings and precautions for use - Natecal D3 tablets are not intended for Olvassa el a teljes dokumentumot